Savara Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Savara Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $0 | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $400.0K | Mar 14, 2018 |
| FY2016 | Sep 30, 2016 | $45.0K | Mar 6, 2017 |
| FY2017 | Dec 31, 2015 | $54.0K | Mar 14, 2018 |
| FY2016 | Dec 31, 2014 | $0 | Mar 6, 2017 |
| FY2014 | Dec 31, 2013 | $0 | Mar 24, 2015 |
| FY2012 | Dec 31, 2012 | $0 | Mar 19, 2013 |
| FY2011 | Dec 31, 2011 | $2.09M | Mar 8, 2012 |
| FY2011 | Dec 31, 2010 | $489.0K | Mar 8, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2020 | $257.0K | Mar 30, 2022 |
| FY2019 | Dec 31, 2019 | $0 | Mar 12, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $2.04M | Mar 26, 2014 |
| FY2012 | Dec 31, 2012 | $2.04M | Mar 19, 2013 |
| FY2011 | Dec 31, 2011 | $2.04M | Mar 8, 2012 |
| FY2011 | Dec 31, 2010 | $489.0K | Mar 8, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($118.84M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($95.88M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | ($54.70M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($38.15M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($43.01M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($49.62M) | Mar 30, 2022 |
| FY2019 | Dec 31, 2019 | ($31.72M) | Mar 12, 2020 |
| FY2019 | Sep 30, 2019 | ($12.40M) | Mar 12, 2020 |
| FY2019 | Jun 30, 2019 | ($21.94M) | Mar 12, 2020 |
| FY2019 | Mar 31, 2019 | ($12.11M) | Mar 12, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($123.55M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($103.20M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | ($60.01M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($38.84M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($41.48M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($49.30M) | Mar 30, 2022 |
| FY2019 | Dec 31, 2019 | ($31.51M) | Mar 12, 2020 |
| FY2019 | Sep 30, 2019 | ($12.44M) | Mar 12, 2020 |
| FY2019 | Jun 30, 2019 | ($22.15M) | Mar 12, 2020 |
| FY2019 | Mar 31, 2019 | ($12.92M) | Mar 12, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $9.34M | Mar 6, 2017 |
| FY2016 | Dec 31, 2015 | $10.96M | Mar 6, 2017 |
| FY2016 | Dec 31, 2014 | $9.49M | Mar 6, 2017 |
| FY2014 | Dec 31, 2013 | $8.52M | Mar 24, 2015 |
| FY2013 | Dec 31, 2012 | $7.52M | Mar 26, 2014 |
| FY2012 | Dec 31, 2011 | $7.19M | Mar 19, 2013 |
| FY2011 | Dec 31, 2010 | $4.99M | Mar 8, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($101.04M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($89.09M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | ($51.06M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($34.55M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($40.08M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($39.84M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($45.12M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($39.28M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($28.23M) | Mar 13, 2019 |
| FY2013 | Dec 31, 2013 | ($17.79M) | Mar 26, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.0K | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $25.0K | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $296.0K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.0K | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $57.0K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $47.0K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $148.0K | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $141.0K | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $495.0K | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $8.0K | Mar 14, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.44M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $212.88M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $177.56M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $139.78M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $176.60M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $97.75M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $136.20M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $152.29M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $159.63M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $28.93M | Mar 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.30M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $41.43M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $37.19M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $32.00M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $32.10M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $33.36M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $34.51M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $44.07M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $40.32M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $20.95M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $203.13M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $171.45M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $140.37M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $107.78M | Mar 27, 2025 |
| FY2023 | Dec 31, 2021 | $144.50M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $64.38M | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | $101.70M | Mar 30, 2022 |
| FY2020 | Dec 31, 2018 | $108.22M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $119.31M | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | ($35.88M) | Mar 13, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $26.92M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $27.08M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $3.05M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $3.01M | Mar 6, 2017 |
| FY2015 | Dec 31, 2014 | $3.01M | Mar 14, 2016 |
| FY2014 | Dec 31, 2013 | $3.01M | Mar 24, 2015 |
| FY2013 | Dec 31, 2012 | $3.01M | Mar 26, 2014 |
| FY2012 | Dec 31, 2011 | $3.01M | Mar 19, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($608.09M) | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($489.25M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | ($393.37M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($338.67M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($300.52M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($257.51M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($207.89M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($129.72M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($68.20M) | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | ($38.41M) | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.18M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $15.13M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $26.59M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $52.10M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $34.01M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $22.88M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $49.80M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $24.30M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $22.12M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $13.37M | Mar 14, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.91M | Mar 13, 2026 |
| FY2024 | Dec 31, 2024 | $26.62M | Mar 27, 2025 |
| FY2023 | Dec 31, 2023 | $26.35M | Mar 7, 2024 |
| FY2022 | Dec 31, 2022 | $26.08M | Mar 30, 2023 |
| FY2021 | Dec 31, 2021 | $25.66M | Mar 30, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 204.57M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 172.42M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 138.14M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 114.05M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 114.04M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 54.15M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 50.79M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | 35.15M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 30.51M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | 3.16M | Mar 14, 2018 |